A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT03148795 · COMPLETED
Trial details
- NCT number
- NCT03148795
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-04
- Primary completion
- 2020-09-04
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.